Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 2,204,650 | 2,392,150 | +187,500 | $37.10M | $47.58M | 29.16% | +$10.48M |
| Nuvation Bio Inc.CL A(NUVB) | 8,081,089 | 8,081,089 | 0 | $72.41M | $34.67M | 21.25% | -$37.74M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 3,289,661 | 3,289,661 | 0 | $41.19M | $29.44M | 18.05% | -$11.74M |
| Kestra Med Technologies Ltd SHS | 1,373,591 | 1,022,149 | -351,442 | $36.43M | $20.37M | 12.49% | -$16.06M |
| Beta Bionics, Inc.(BBNX) | 1,316,183 | 1,316,183 | 0 | $40.10M | $13.19M | 8.08% | -$26.92M |
| enGene Holdings Inc. COM | 876,357 | 876,357 | 0 | $7.91M | $5.97M | 3.66% | -$1.95M |
| Alumis Inc. | 653,223 | 241,255 | -411,968 | $6.38M | $5.31M | 3.26% | -$1.06M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $3.43M | $2.43M | 1.49% | -$1.00M |
| ImageneBio, Inc.(IMA) | 455,361 | 455,361 | 0 | $3.14M | $2.28M | 1.40% | -$865.2K |
| Replimune Group, Inc.(REPL) | 248,672 | 248,672 | 0 | $2.42M | $1.91M | 1.17% | -$507.3K |
| Upstream Bio, Inc.(UPB) | 1,326,293 | 0 | -1,326,293 | $36.01M | $0 | — | -$36.01M |